"One of the biggest findings uncovered by FreshLeaf's Q3 2019 report—which is the most comprehensive analysis of the cannabis industry to date—is that the number of new products available to Australian consumers has skyrocketed, growing by more than 40% in just 6 months.
Based on these trends, FreshLeaf is now predicting that the number of SAS-B approvals will reach a total of 28,301 by the end of 2019, representing more than 1,000% growth on the previous year."
MXC Price at posting:
3.1¢ Sentiment: Buy Disclosure: Held
